Pulmonx Corporation provided earnings Guidance for 2023. For the period, the company is increasing its expectation for revenue to now range from $67 million to $68 million, which represents approximately 25% to 27% growth over the Company's fiscal year 2022 revenue. This updated guidance compares to prior 2023 revenue guidance of $64 million to $66 million.